Progressive multifocal leucoencephalopathy associated with lupus and methotrexate overdose

Lupus

Volumn 17, Issue 11, 2008, Pages 1029-1032

  Shprecher, David ^a   Frech, T ^b   Chin, S ^b   Eskandari, R ^b   Steffens, J ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

Author keywords

Demyelinating disease; Leucoencephalopathy; PML; Systemic lupus erythematosus; Viral infections

Indexed keywords

CARDIOLIPIN ANTIBODY; METHOTREXATE; PREDNISONE; WARFARIN;

ADULT; ARTHRALGIA; ARTICLE; BRAIN ANGIOGRAPHY; BRAIN BIOPSY; CASE REPORT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL EXAMINATION; COMPUTER ASSISTED TOMOGRAPHY; DEATH; DISEASE ASSOCIATION; DRUG INTERMITTENT THERAPY; DRUG OVERDOSE; FEMALE; HUMAN; JC VIRUS; MEDICATION ERROR; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; SYSTEMIC LUPUS ERYTHEMATOSUS; TREATMENT REFUSAL; INTOXICATION; MIDDLE AGED;

FEMALE; HUMANS; LEUKOENCEPHALOPATHY, PROGRESSIVE MULTIFOCAL; LUPUS ERYTHEMATOSUS, SYSTEMIC; METHOTREXATE; MIDDLE AGED; OVERDOSE;

EID: 61549101481     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203308089435     Document Type: Article

References (39)

1. Rituxan warning. FDA Consum 2007; 41: 3.
2. Ahmed F Aziz T Kaufman LD. Progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. J Rheumatol 1999; 26: 1609-1612.
3. Aksamit AJ. Review of progressive multifocal leukoencephalopathy and natalizumab. Neurologist 2006; 12: 293-298.
4. Arbusow V Strupp M Pfister HW Seelos KC Bruckmann H Brandt T. Contrast enhancement in progressive multifocal leukoencephalopathy: A predictive factor for long-term survival? J Neurol 2000; 247: 306-308.
5. Itoh K Kano T Nagashio C Mimori A Kinoshita M Sumiya M. Progressive multifocal leukoencephalopathy in patients with systemic lupus erythematosus. Arthritis Rheum 2006; 54: 1020-1022.
6. Jones HR Hedley-Whyte ET Freidberg SR Kelleher JE Krolikowski J. Primary cerebellopontine progressive multifocal leukoencephalopathy diagnosed premortem by cerebellar biopsy. Ann Neurol 1982; 11: 199-202.
7. Kaye BR Neuwelt CM London SS DeArmond SJ. Central nervous system systemic lupus erythematosus mimicking progressive multifocal leucoencephalopathy. Ann Rheum Dis 1992; 51: 1152-1156.
8. Kinoshita M Iwana K Shinoura H Aotsuka S Sumiya M. Progressive multifocal leukoencephalopathy resembling central nervous system systemic lupus erythematosus. Clin Exp Rheumatol 1998; 16: 313-315.
9. Malas D Weiss S. Progressive multifocal leukoencephalopathy and cryptococcal meningitis with systemic lupus erythematosus and thymoma. Ann Neurol 1977; 1: 188-191.
10. Newton P Aldridge RD Lessells AM Best PV. Progressive multifocal leukoencephalopathy complicating systemic lupus erythematosus. Arthritis Rheum 1986; 29: 337-343.
11. Reilmann R Imai T Ringelstein EB. et al Remission of progressive multifocal leucoencephalopathy in SLE after treatment with cidofovir: A 4 year follow up. J Neurol Neurosurg Psychiatry 2005; 76: 1304-1305.
12. Salmaggi A Maccagnano E Castagna A. et al Reversal of CSF positivity for JC virus genome by cidofovir in a patient with systemic lupus erythematosus and progressive multifocal leukoencephalopathy. Neurol Sci 2001; 22: 17-20.
13. Tomura N Watanabe M Kato T Nishino K Kowada M. Case report: Progressive multifocal leukoencephalopathy with prominent medullary veins on angiogram. Clin Radiol 1994; 49: 66-68.
14. Vandecasteele SJ Maes B Claes K Sciot R Vanrenterghem Y. High anti-double-stranded DNA antibodies and progressive multifocal leukoencephalopathy in a patient with systemic lupus erythematosus. Nephrol Dial Transplant 2005; 20: 1246-1247.
15. Warnatz K Peter HH Schumacher M. et al Infectious CNS disease as a differential diagnosis in systemic rheumatic diseases: Three case reports and a review of the literature. Ann Rheum Dis 2003; 62: 50-57.
16. Weiner LP Herndon RM Narayan O. et al Isolation of virus related to SV40 from patients with progressive multifocal leukoencephalopathy. N Engl J Med 1972; 286: 385-390.
17. Brey RL Holliday SL Saklad AR. et al Neuropsychiatric syndromes in lupus: Prevalence using standardized definitions. Neurology 2002; 58: 1214-1220.
18. Sanna G Bertolaccini ML Cuadrado MJ Khamashta MA Hughes GR. Central nervous system involvement in the antiphospholipid (Hughes) syndrome. Rheumatology 2003; 42: 200-213.
19. Joseph FG Lammie GA Scolding NJ. CNS lupus: A study of 41 patients. Neurology 2007; 69: 644-654.
20. Lima MA Drislane FW Koralnik IJ. Seizures and their outcome in progressive multifocal leukoencephalopathy. Neurology 2006; 66: 262-264.
21. Post MJ Yiannoutsos C Simpson D. et al Progressive multifocal leukoencephalopathy in AIDS: Are there any MR findings useful to patient management and predictive of patient survival? AIDS Clinical Trials Group, 243 Team. AJNR Am J Neuroradiol 1999; 20: 1896-1906.
22. Viallard JF Ellie E Lazaro E Lafon ME Pellegrin JL. JC virus meningitis in a patient with systemic lupus erythematosus. Lupus 2005; 14: 964-966.
23. Asato R Akiyama Y Ito M. et al Nuclear magnetic resonance abnormalities of the cerebral white matter in children with acute lymphoblastic leukemia and malignant lymphoma during and after central nervous system prophylactic treatment with intrathecal methotrexate. Cancer 1992; 70: 1997-2004.
24. Renard D Westhovens R Vandenbussche E Vandenberghe R. Reversible posterior leucoencephalopathy during oral treatment with methotrexate. J Neurol 2004; 251: 226-228.
25. Yokoo H Nakazato Y Harigaya Y Sasaki N Igeta Y Itoh H. Massive myelinolytic leukoencephalopathy in a patient medicated with low-dose oral methotrexate for rheumatoid arthritis: An autopsy report. Acta Neuropathol 2007; 114: 425-430.
26. Worthley SG McNeil JD. Leukoencephalopathy in a patient taking low dose oral methotrexate therapy for rheumatoid arthritis. J Rheumatol 1995; 22: 335-337.
27. Raghavendra S Nair MD Chemmanam T Krishnamoorthy T Radhakrishnan VV Kuruvilla A. Disseminated necrotizing leukoencephalopathy following low-dose oral methotrexate. Eur J Neurol 2007; 14: 309-314.
28. McEvoy GK ed. Methotrexate. In: AHFS drug information 2004. Bethesda, MD: American Society of Health-System Pharmacists; 2006: 1088.
29. Berger JR Levy RM Flomenhoft D Dobbs M. Predictive factors for prolonged survival in acquired immunodeficiency syndrome-associated progressive multifocal leukoencephalopathy. Ann Neurol 1998; 44: 341-349.
30. Du Pasquier RA Kuroda MJ Zheng Y Jean-Jacques J Letvin NL Koralnik IJ. A prospective study demonstrates an association between JC virus-specific cytotoxic T lymphocytes and the early control of progressive multifocal leukoencephalopathy. Brain 2004; 127: 1970-1978.
31. Van Assche G Van Ranst M Sciot R. Progressive multifocal leukoencephalopathy after natalizumab therapy for Crohn's disease. N Engl J Med 2005; 353: 362-368.
32. Langer-Gould A Atlas SW Green AJ Bollen AW Pelletier D. Progressive multifocal leukoencephalopathy in a patient treated with natalizumab. N Engl J Med 2005; 353: 375-381.
33. Kleinschmidt-DeMasters BK Tyler KL. Progressive multifocal leukoencephalopathy complicating treatment with natalizumab and interferon beta-1a for multiple sclerosis. N Engl J Med 2005; 353: 369-374.
34. Wang H Xu J Ji X. et al The abnormal apoptosis of T cell subsets and possible involvement of IL-10 in systemic lupus erythematosus. Cell Immunol 2005; 235: 117-121.
35. Aksamit AJ. Treatment of non-AIDS progressive multifocal leukoencephalopathy with cytosine arabinoside. J Neurovirol 2001; 7: 386-390.
36. Albrecht H Hoffmann C Degen O. et al Highly active antiretroviral therapy significantly improves the prognosis of patients with HIV-associated progressive multifocal leukoencephalopathy. AIDS 1998; 12: 1149-1154.
37. Garrels K Kucharczyk W Wortzman G Shandling M. Progressive multifocal leukoencephalopathy: Clinical and MR response to treatment. AJNR Am J Neuroradiol 1996; 17: 597-600.
38. Vulliemoz S Lurati-Ruiz F Borruat FX. et al Favourable outcome of progressive multifocal leucoencephalopathy in two patients with dermatomyositis. J Neurol Neurosurg Psychiatry 2006; 77: 1079-1082.
39. Elphick GF Querbes W Jordan JA. et al The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 2004; 306: 1380-1383.